Clinical trials
Terminated Sarcoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gynecologic Oncology Group | 3 |
| AHS Cancer Control Alberta | 1 |
| Alaunos Therapeutics | 1 |
| Champions Oncology | 1 |
| Children's Oncology Group | 1 |
| Elevation Oncology | 1 |
| Hoffmann-La Roche | 1 |
| Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| MacroGenics | 1 |
| Ocellaris Pharma, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 17 |
| Breast Neoplasms | 4 |
| Prostatic Neoplasms | 4 |
| Colorectal Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Ovarian Neoplasms | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Urinary Bladder Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma, Renal Cell | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.